Effect of MD1003 (high dose Pharmaceutical grade Biotin) in the Treatment of Progressive MS: Earlier Treatment Results in Lower Disability Over 48 Months
https://n.neurology.org/content/92/15_S ... 3.abstract
Conclusions: Results from the MS-SPI study at 4 years of follow-up indicate that 1) delayed MD1003 treatment results in higher disability over time, 2) pts show improvement when switching from placebo to MD1003, and 3) the effects of MD1003 observed in the double-blind phase are sustained over time.
Biotin. Good results in progressive MS
-
- Similar Topics
- Replies
- Views
- Last post